201 related articles for article (PubMed ID: 20374200)
41. Wnt4 and LAP2alpha as pacemakers of thymic epithelial senescence.
Kvell K; Varecza Z; Bartis D; Hesse S; Parnell S; Anderson G; Jenkinson EJ; Pongracz JE
PLoS One; 2010 May; 5(5):e10701. PubMed ID: 20502698
[TBL] [Abstract][Full Text] [Related]
42. Rosiglitazone promotes PPARγ-dependent and -independent alterations in gene expression in mouse islets.
Welters HJ; El Ouaamari A; Kawamori D; Meyer J; Hu J; Smith DM; Kulkarni RN
Endocrinology; 2012 Oct; 153(10):4593-9. PubMed ID: 22807489
[TBL] [Abstract][Full Text] [Related]
43. Thymic involution in aging.
Aspinall R; Andrew D
J Clin Immunol; 2000 Jul; 20(4):250-6. PubMed ID: 10939712
[TBL] [Abstract][Full Text] [Related]
44. Dissociation of antihyperglycaemic and adverse effects of partial perioxisome proliferator-activated receptor (PPAR-gamma) agonist balaglitazone.
Larsen PJ; Lykkegaard K; Larsen LK; Fleckner J; Sauerberg P; Wassermann K; Wulff EM
Eur J Pharmacol; 2008 Oct; 596(1-3):173-9. PubMed ID: 18761337
[TBL] [Abstract][Full Text] [Related]
45. CMHX008, a novel peroxisome proliferator-activated receptor γ partial agonist, enhances insulin sensitivity in vitro and in vivo.
Ming Y; Hu X; Song Y; Liu Z; Li J; Gao R; Zhang Y; Mei H; Guo T; Xiao L; Wang B; Wu C; Xiao X
PLoS One; 2014; 9(7):e102102. PubMed ID: 25004107
[TBL] [Abstract][Full Text] [Related]
46. Overexpression of Foxn1 attenuates age-associated thymic involution and prevents the expansion of peripheral CD4 memory T cells.
Zook EC; Krishack PA; Zhang S; Zeleznik-Le NJ; Firulli AB; Witte PL; Le PT
Blood; 2011 Nov; 118(22):5723-31. PubMed ID: 21908422
[TBL] [Abstract][Full Text] [Related]
47. The Role of Dietary Phytoestrogens and the Nuclear Receptor PPARγ in Adipogenesis: An in Vitro Study.
Hall JM; Powell HA; Rajic L; Korach KS
Environ Health Perspect; 2019 Mar; 127(3):37007. PubMed ID: 30920877
[TBL] [Abstract][Full Text] [Related]
48. Lack of Adipocytes Alters Hematopoiesis in Lipodystrophic Mice.
Wilson A; Fu H; Schiffrin M; Winkler C; Koufany M; Jouzeau JY; Bonnet N; Gilardi F; Renevey F; Luther SA; Moulin D; Desvergne B
Front Immunol; 2018; 9():2573. PubMed ID: 30483254
[TBL] [Abstract][Full Text] [Related]
49. Effects of DSP-8658, a novel selective peroxisome proliferator-activated receptors a/γ modulator, on adipogenesis and glucose metabolism in diabetic obese mice.
Goto T; Nakayama R; Yamanaka M; Takata M; Takazawa T; Watanabe K; Maruta K; Nagata R; Nagamine J; Tsuchida A; Kato H
Exp Clin Endocrinol Diabetes; 2015 Sep; 123(8):492-9. PubMed ID: 26011171
[TBL] [Abstract][Full Text] [Related]
50. The tumour suppressor CDKN2A/p16
Wouters K; Deleye Y; Hannou SA; Vanhoutte J; Maréchal X; Coisne A; Tagzirt M; Derudas B; Bouchaert E; Duhem C; Vallez E; Schalkwijk CG; Pattou F; Montaigne D; Staels B; Paumelle R
Diab Vasc Dis Res; 2017 Nov; 14(6):516-524. PubMed ID: 28868898
[TBL] [Abstract][Full Text] [Related]
51. Coordinate functional regulation between microsomal prostaglandin E synthase-1 (mPGES-1) and peroxisome proliferator-activated receptor γ (PPARγ) in the conversion of white-to-brown adipocytes.
García-Alonso V; López-Vicario C; Titos E; Morán-Salvador E; González-Périz A; Rius B; Párrizas M; Werz O; Arroyo V; Clària J
J Biol Chem; 2013 Sep; 288(39):28230-42. PubMed ID: 23943621
[TBL] [Abstract][Full Text] [Related]
52. JTP-426467 acts as a selective antagonist for peroxisome proliferator-activated receptor gamma in vitro and in vivo.
Nishiu J; Ito M; Ishida Y; Kakutani M; Shibata T; Matsushita M; Shindo M
Diabetes Obes Metab; 2006 Sep; 8(5):508-16. PubMed ID: 16918585
[TBL] [Abstract][Full Text] [Related]
53. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer.
Lin MS; Chen WC; Bai X; Wang YD
J Dig Dis; 2007 May; 8(2):82-8. PubMed ID: 17532820
[TBL] [Abstract][Full Text] [Related]
54. Identification of a novel selective agonist of PPARγ with no promotion of adipogenesis and less inhibition of osteoblastogenesis.
Liu C; Feng T; Zhu N; Liu P; Han X; Chen M; Wang X; Li N; Li Y; Xu Y; Si S
Sci Rep; 2015 Apr; 5():9530. PubMed ID: 25827822
[TBL] [Abstract][Full Text] [Related]
55. Acute genome-wide effects of rosiglitazone on PPARγ transcriptional networks in adipocytes.
Haakonsson AK; Stahl Madsen M; Nielsen R; Sandelin A; Mandrup S
Mol Endocrinol; 2013 Sep; 27(9):1536-49. PubMed ID: 23885096
[TBL] [Abstract][Full Text] [Related]
56. Peroxisome Proliferator-Activated Receptor γ and Its Role in Adipocyte Homeostasis and Thiazolidinedione-Mediated Insulin Sensitization.
Wang QA; Zhang F; Jiang L; Ye R; An Y; Shao M; Tao C; Gupta RK; Scherer PE
Mol Cell Biol; 2018 May; 38(10):. PubMed ID: 29483301
[TBL] [Abstract][Full Text] [Related]
57. Age-associated remodeling of thymopoiesis: role for gonadal hormones and catecholamines.
Leposavić G; Perisić M
Neuroimmunomodulation; 2008; 15(4-6):290-322. PubMed ID: 19047807
[TBL] [Abstract][Full Text] [Related]
58. Activation of CCAAT/enhancer-binding protein (C/EBP) alpha expression by C/EBP beta during adipogenesis requires a peroxisome proliferator-activated receptor-gamma-associated repression of HDAC1 at the C/ebp alpha gene promoter.
Zuo Y; Qiang L; Farmer SR
J Biol Chem; 2006 Mar; 281(12):7960-7. PubMed ID: 16431920
[TBL] [Abstract][Full Text] [Related]
59. Glucocorticoids delay age-associated thymic involution through directly affecting the thymocytes.
Pazirandeh A; Jondal M; Okret S
Endocrinology; 2004 May; 145(5):2392-401. PubMed ID: 14736739
[TBL] [Abstract][Full Text] [Related]
60. Thiazolidinedione drugs down-regulate CXCR4 expression on human colorectal cancer cells in a peroxisome proliferator activated receptor gamma-dependent manner.
Richard CL; Blay J
Int J Oncol; 2007 May; 30(5):1215-22. PubMed ID: 17390024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
